Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

UPTRAVI - 200mcg - 140

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
B01AC27 B Selexipag - 200mcg 10409/945 14720/1 UPTRAVI 200mcg 140 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 613,462,617 L.L 2.44 E2 Janssen Cilag International NV Belgium 2/5/2024

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
B01AC27 B Selexipag - 200mcg 10408 14620/1 UPTRAVI 200mcg 60 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 4,512,270 L.L 2.44 E2 Janssen Cilag International NV Belgium 2/5/2024
B01AC27 B Selexipag - 200mcg 10409 14720/1 UPTRAVI 200mcg 140 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 10,062,280 L.L 2.44 E2 Janssen Cilag International NV Belgium 2/5/2024
B01AC27 B Selexipag - 200mcg 10408/945 14620/1 UPTRAVI 200mcg 60 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 275,097,581 L.L 2.44 E2 Janssen Cilag International NV Belgium 2/5/2024
Sitemap
© Copyrights reserved to Ministry of Public Health 2024